Developer of nanotherapeutics designed to enhance drug and gene delivery for kidney and cardiovascular diseases. The company specializes in Peptide Amphiphile Micelles (PAMs) to target specific disease sites, improving the efficacy and safety of drug and gene therapies, enabling clinicians to reduce side effects and enhance treatment outcomes for patients with kidney and cardiovascular conditions.
Is this your company?
Something looks off?